Authors:
Girdler, F
Browell, DA
Cunliffe, WJ
Shenton, BK
Hemming, JD
Scorer, P
Young, JR
Brotherick, I
Citation: F. Girdler et al., Use of the monoclonal antibody DAKO-ER beta (8D5-1) to measure oestrogen receptor beta in breast cancer cells, CYTOMETRY, 45(1), 2001, pp. 65-72
Authors:
Hodgson, DR
Clayton, SJ
Girdler, F
Brotherick, I
Shenton, B
Browell, D
Stuart, M
Fox, JC
Ceuppens, P
Foy, CA
Whitcombe, D
Gibson, NJ
Citation: Dr. Hodgson et al., ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast, CLIN CHEM, 47(4), 2001, pp. 774-778
Citation: F. Girdler et I. Brotherick, The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review, BREAST, 9(4), 2000, pp. 194-200
Citation: Gc. Durkan et al., The impact of transurethral resection of bladder tumour on serum levels ofsoluble E-cadherin, BJU INT, 83(4), 1999, pp. 424-428
Authors:
Watson, DS
Brotherick, I
Shenton, BK
Wilson, RG
Angus, B
Varma, JS
Campbell, FC
Citation: Ds. Watson et al., Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer, ONCOL-BASEL, 56(1), 1999, pp. 66-72
Authors:
Cook, DB
Bustaman, AA
Brotherick, I
Shenton, BK
Self, CH
Citation: Db. Cook et al., Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls, CLIN CHEM, 45(2), 1999, pp. 292-295
Authors:
Karat, D
Brotherick, I
Shenton, BK
Scott, D
Raimes, SA
Griffin, SM
Citation: D. Karat et al., Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study, BR J CANC, 80(8), 1999, pp. 1271-1274